Skip to main content

The Chinese government has withdrawn its approval for Facebook Inc’s plan to open a venture in the eastern province of Zhejiang, the New York Times reported on Wednesday, citing a person familiar with the matter.

Facebook said on Tuesday it planned to create an “innovation hub” to support local start-ups.

The subsidiary was registered in Hangzhou, according to a filing approved on China’s National Enterprise Credit Information Publicity System last week and seen by Reuters on Tuesday.

Story continues below advertisement

A Chinese government database showed that Facebook had gained approval to open a subsidiary. The registration has since disappeared, according to checks made by Reuters.

Facebook could not be immediately reached for comment.

Shares of Facebook reversed course to trade marginally down at $214.40 after touching a record high earlier in the session.

The decision to take down the approval came after a disagreement between officials in Zhejiang and the national internet regulator, the Cyberspace Administration of China, which was angry that it had not been consulted more closely, according to the New York Times.

The Chinese internet regulator was not immediately available for comment.

While the about-face does not definitively end Facebook’s chances of establishing the company, it makes success very unlikely, a source told the New York Times.

Facebook is the latest company to get caught in the crosshairs of rising U.S.-China trade tensions. U.S. chipmaker Qualcomm Inc’s proposed bid to buy NXP Semiconductors NV has also got stuck awaiting approval from Chinese regulators.

Story continues below advertisement

Facebook’s website remains banned in China, which strictly censors foreign news outlets, search engines and social media including content from Twitter Inc and Alphabet Inc’s Google.

Facebook’s messaging app WhatsApp is also blocked in the country.

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies